Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Department of Immunology, University of Regensburg, Regensburg, Germany.
Immunity. 2017 Jul 18;47(1):80-92.e4. doi: 10.1016/j.immuni.2017.05.008. Epub 2017 Jul 11.
Lymph nodes (LNs) are strategically situated throughout the body at junctures of the blood vascular and lymphatic systems to direct immune responses against antigens draining from peripheral tissues. The current paradigm describes LN development as a programmed process that is governed through the interaction between mesenchymal lymphoid tissue organizer (LTo) cells and hematopoietic lymphoid tissue inducer (LTi) cells. Using cell-type-specific ablation of key molecules involved in lymphoid organogenesis, we found that initiation of LN development is dependent on LTi-cell-mediated activation of lymphatic endothelial cells (LECs) and that engagement of mesenchymal stromal cells is a succeeding event. LEC activation was mediated mainly by signaling through receptor activator of NF-κB (RANK) and the non-canonical NF-κB pathway and was steered by sphingosine-1-phosphate-receptor-dependent retention of LTi cells in the LN anlage. Finally, the finding that pharmacologically enforced interaction between LTi cells and LECs promotes ectopic LN formation underscores the central LTo function of LECs.
淋巴结(LNs)在全身血管系统和淋巴系统的交界处战略性地分布,以指导针对来自外周组织的抗原的免疫反应。目前的范式描述了 LN 发育是一个程序化的过程,受间充质淋巴组织组织者(LTo)细胞和造血淋巴组织诱导(LTi)细胞之间的相互作用的控制。使用涉及淋巴器官发生的关键分子的细胞类型特异性消融,我们发现 LN 发育的启动依赖于 LTi 细胞介导的淋巴内皮细胞(LEC)的激活,并且间充质基质细胞的参与是随后的事件。LEC 的激活主要通过受体激活物 NF-κB(RANK)和非经典 NF-κB 途径的信号转导介导,并且由 LTi 细胞在 LN 原基中通过鞘氨醇-1-磷酸受体依赖性保留来指导。最后,发现 LTi 细胞和 LEC 之间药理学强制相互作用促进异位 LN 形成,突出了 LEC 作为 LTo 的核心功能。